注射用兰索拉唑用药医嘱分析及临床安全注意点  

Analysis of medication advice on lansoprazole injection and points for safety in clinical medication

作　　者：张苏蘅[1] 王晓妮 康阿龙[1] 

机构地区：[1]解放军第四五一医院药剂科,西安710054

出　　处：《药学服务与研究》2017年第5期359-362,共4页Pharmaceutical Care and Research

摘　　要：目的:分析住院病人注射用兰索拉唑临床应用的合理性及评估存在的安全风险,为临床安全用药提供参考。方法:调查357例使用注射用兰索拉唑的住院病人的性别、年龄、用药目的、用药频次、疗程、有无适应证等资料,制定用药评价标准,分析其使用合理性、临床使用安全风险及注意点。结果:357例中存在不合理用药医嘱235例(65.8%),显示存在滥用、过度使用和不规范使用情况,主要问题为无适应证用药和超疗程用药,存在的安全风险主要集中在医嘱开具、医嘱审核、输注过程三个环节。结论:需通过培训教育、加强医嘱审核、提高质控强度等多种举措,消除使用过程中的安全风险,提高安全用药水平。Objective：To analyze the rationality of clinical medication of lansoprazole injection and assess the risks involved,so as to provide evidence for clinical safe medication.Methods：Data concerning gender,age,aim/frequency/course of medication,and indications were collected from the randomly-selected 357 inpatients,and rationality,risks involved and points for safety in clinical medication were analyzed.Results：Of the 357 cases,235 cases（65.8%）were found to have drug abuse and excessive or non-standard medication,with the main problems of non-indication medication and excessively long treatment courses.The safety risks were mainly found in the prescription of medical advice,medical advice monitoring and drug infusion.Conclusion：The elimination of safety risks and improvement of safe medication could be achieved through the implementation of such measures as training and education,strengthening of medical advice monitoring and intensifying of quality control.

关 键 词：注射用兰索拉唑 医嘱 用药评价 

分 类 号：R975.6[医药卫生—药品]